HAS
GILD icon

HBW Advisory Services’s Gilead Sciences GILD Stock Holding History

HBW Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$442K Buy
3,501
+110
+3% +$14.5K 0.04% 325
2026
Q1 		$473K Buy
3,391
+79
+2% +$11.1K 0.05% 297
2025
Q4 		$407K Buy
3,312
+190
+6% +$23.1K 0.04% 303
2025
Q3 		$347K Buy
3,122
+114
+4% +$13K 0.04% 316
2025
Q2 		$334K Sell
3,008
-357
-11% -$38K 0.04% 302
2025
Q1 		$377K Buy
3,365
+262
+8% +$27K 0.05% 250
2024
Q4 		$287K Buy
3,103
+55
+2% +$4.95K 0.03% 284
2024
Q3 		$256K Sell
3,048
-68
-2% -$5.19K 0.04% 307
2024
Q2 		$214K Buy
3,116
+19
+0.6% +$1.27K 0.04% 312
2024
Q1 		$251K Hold
3,097
– – 0.05% 259
2023
Q4 		$251K Sell
3,097
-126
-4% -$9.8K 0.05% 259
2023
Q3 		$242K Buy
+3,223
New +$248K 0.05% 240

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HBW Advisory Services's GILD Position: Q2 2026 in Review

HBW Advisory Services increased its Gilead Sciences (GILD) stake by 3.2% in Q2 2026, buying an estimated $14.5K and bringing the position to 3,501 shares worth $442K. The position accounts for 0.04% of the portfolio, ranked #325.

HBW Advisory Services first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $473K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • HBW Advisory Services held 3,501 shares of Gilead Sciences worth $442K as of Q2 2026.
  • HBW Advisory Services bought 110 Gilead Sciences shares in Q2 2026, an estimated $14.5K.
  • Gilead Sciences made up 0.04% of HBW Advisory Services's portfolio in Q2 2026, its #325 holding.
  • HBW Advisory Services first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • HBW Advisory Services's Gilead Sciences position peaked at $473K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.